Abbott Laboratories (ABT) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $102.98 +0.36%
Revenue Growth %: +14.2%
Financial Fact:
Selling, general and administrative: 1.63B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +14.2%
Financial Fact:
Selling, general and administrative: 1.63B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.51, $0.01 better than the analyst estimate of $1.50. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.58 billion.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Credo Technology shares rise on analyst support and conference comments
- Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
